ESC 365 - Professor Dominick Joseph Angiolillo

Speaker illustration

Professor Dominick Joseph Angiolillo

University of Florida, Jacksonville (United States of America)

Member of:

Dominick Angiolillo is a Professor of Medicine, Chief of Cardiology, Medical Director of the Cardiovascular Center, Director of Cardiovascular Research, Program Director of the Interventional Cardiology Fellowship Program at the University of Florida. Much of Dr. Angiolillo’s professional career has been devoted to cardiovascular research in the field of interventional cardiology and acute coronary syndrome. His largest national and international recognition has been for his pivotal contributions in the field of thrombosis. In particular, Dr. Angiolillo has performed seminal studies on platelet function and modulation of antiplatelet drug response, including genetic studies, for which he has received numerous national and international academic recognitions. He has also been a key investigator in the clinical development of numerous novel antithrombotic agents. Dr. Angiolillo has made major scientific contributions to many medical and cardiovascular journals, as well as textbooks.

Sessions Presentations Events Articles Podcasts

Implementation in real-world practice of ESC Guidelines for the acute management of patients with NSTE-ACS

Event: ESC Congress 2023

Topic: Antiplatelet Drugs

Session type: Satellite Symposium

Long-term PCI outcomes

Event: ESC Congress 2022

Topic: Percutaneous Coronary Intervention (PCI)

Session type: Moderated ePosters

NOACs in patients with atrial fibrillation: insights from the cardiac cath lab

Event: ESC Congress 2020

Topic: Stroke Prevention

Session type: Industry Q&A session

NOACs in patients undergoing cardiac procedures

Event: ESC Congress 2019

Topic: Atrial Fibrillation (AF)

Session type: Satellite Symposium

Bleeding complications in ACS

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session type: Abstract Sessions

Residual cardiovascular risk after an acute coronary syndrome: identifying, stratifying and managing patients at long term risk of atherothrombotic cardiovascular events (EBAC Accredited)

Event: ESC Congress 2018

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Satellite Symposium

Residual cardiovascular risk after an acute coronary syndrome: identifying, stratifying and managing patients at long term risk of atherothrombotic cardiovascular events (EBAC Accredited)

Event: ESC Congress 2018

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Satellite Symposium - Experts on the Spot

Acute coronary syndromes in challenging situations

Event: ESC Congress 2017

Topic: Infarction acute phase non STEMI

Session type: Meet the Experts

Bridging of antithrombotic therapy for invasive procedure

Event: ESC Congress 2016

Topic: Antithrombotic agents

Session type: Symposium

ESC 365 is supported by